Background. It is unknown whether adverse pregnancyrelated outcomes in women with pregestational diabetes are associated with later development of end-stage renal disease (ESRD) or death. Methods. We linked data from the Medical Birth Registry of Norway with data from the Norwegian Renal Registry and the Norwegian Cause of Death Registry. Data from up to three pregnancies for women with a first singleton delivery from 1967 to 1994 were included and analysed in a cohort design using Cox regression. Results. Altogether, 639 018 women were included in the analyses, among whom 2204 women had diabetes mellitus before pregnancy. Their first pregnancy was complicated by pre-eclampsia in 13.2%, low birth weight offspring (<2.5 kg) in 11.0% and preterm birth in 25.1%, and their risk of ESRD and death in the follow-up period of up to 37 years was markedly higher. In women with pregestational diabetes, pre-eclampsia and preterm birth were associated with significantly increased risks of ESRD and death in women with only one pregnancy, but not in women with two or more pregnancies. Conclusions. In women with pregestational diabetes, preeclampsia and preterm birth were associated with longterm increased risk of ESRD and death, but only in women who had only one pregnancy.
Introduction
Several studies have suggested an association between preeclampsia and development of cardiovascular disease [1] [2] [3] [4] and renal disease [5] . In a large national cohort study, we recently showed that women who had had pre-eclampsia had a four to five times increased risk for later end-stage renal disease (ESRD) [6] . Based on these studies, recent review papers have advocated that women who have had preeclampsia might benefit from closer follow-up than women who have not had pre-eclampsia [7, 8] .
In the Western world, diabetic nephropathy is a major cause of ESRD. There are, however, considerable differences between countries; in Norway, diabetic nephropathy is recorded as the cause of ESRD in 10-15% of the patients [9] , while in the United States, the percentage is ∼50% [10] . There is a need for more knowledge of risk factors for development and progression of diabetic nephropathy, and as the prevalence of diabetes mellitus in fertile women has increased in recent years [11, 12] , more knowledge of the significance of pregnancy-related factors is needed. Some studies have showed worsening of diabetic nephropathy during pregnancy [13] [14] [15] , although this has been disputed by others [16] [17] [18] [19] . How pregnancyrelated factors interact with pregestational diabetes as determinants of ESRD still remains uncertain.
The aim of the present study was to assess to which extent adverse pregnancy outcomes were associated with later development of ESRD or premature death in women with diabetes, and also to assess whether diabetes modified the effects of adverse pregnancy outcomes.
Materials and methods

Registries involved
Since 1967, medical data on all births in Norway (total population of 4.5 million inhabitants) with a gestational age of at least 16 weeks have, by compulsory notification, been forwarded to the Medical Birth Registry of Norway [20] . For the present study, data from the Medical Birth Registry were available through 2004. The notification form includes extensive data on the mother and the newborn and is completed by the attending midwife and doctor. Data are coded at the registry using the International Classification of Diseases (8th revision 1967-1998 and 10th revision from 1999).
Since 1980, data on all patients in Norway developing ESRD (defined as starting chronic dialysis treatment or undergoing renal transplantation) have been registered in the Norwegian Renal Registry, and data were available through December 2005. The National Cause of Death Registry comprises data on all deaths, available through December 2004.
Selection of study sample and definitions of diabetes
We included data from up to three pregnancies for all women who gave birth to their first child between 1967 and 1994. Women with multiple deliveries were excluded. We used the national identification number for data linkage with the Norwegian Renal Registry and the National Cause of Death Registry. Based on data from the woman's general practitioner or obstetrician, the Medical Birth Registry is notified when a diagnosis of pregestational diabetes has been made accordingly to diagnostic criteria at the time of registration. Data on glycaemic control before or during pregnancy or detailed data on neuropathy, nephropathy or retinopathy are not completely recorded. Until 1999, the Medical Birth Registry did not register type of diabetes, and duration of diabetes before pregnancy. For use in the present study, women were classified as having diabetes if they had been registered with pregestational diabetes in their last recorded pregnancy (of maximum three) or if they had been registered with pregestational diabetes in at least two pregnancies.
Other exposure variables
Criteria for pre-eclampsia used by the reporting midwives and obstetricians have been in accordance with the 1972 recommendations by the American College of Obstetrics and Gynecologists [21] ; increased blood pressure after 20 weeks' gestation (blood pressure 140/90 mm Hg or greater) and proteinuria (0.3 g or more in a 24-h urine specimen or +1 or greater on urinary dipstick).
Birth weight is measured shortly after birth; a weight below 2.5 kg was categorized as low birth weight. From 1967 to 1998, the estimation of gestational age was based on the last menstrual period, and from 1999 onwards on routine ultrasonographic examination between gestational weeks 17 and 20. Birth at a gestational age below 37 weeks was defined as preterm. A child was recorded as small for gestational age if the weight was in the lowest 10th gestational age-specific percentile, and large for gestational age if the weight was in the highest 10th percentile, based on gender-specific reference values for Norway [22] .
Pre-pregnancy data on kidney or urinary tract disease and essential hypertension were obtained from the Medical Birth Registry. A birth was recorded as a stillbirth if death occurred before or during labour. Marital status was dichotomized as either single (divorced or not living with partner) or not single (married or living with partner). Congenital malformations in offspring were recorded as present if any congenital malformation was reported shortly after birth. Year of birth and maternal age at birth were included as continuous variables. Mode of delivery was dichotomized as caesarean section or vaginal.
Statistical analyses
Data were analysed in a cohort design using pregnancy-related variables and pregestational diabetes as exposure variables, and ESRD (defined as starting dialysis treatment or undergoing renal transplantation) and death as outcome variables. First, we analysed to which extent diabetes was associated with adverse pregnancy outcomes, ESRD or death. Second, we analysed whether adverse pregnancy outcomes in the first pregnancy were associated with ESRD or death in women with diabetes. The second sets of analyses were stratified based on the number of lifetime pregnancies. Baseline was set at the date of the first pregnancy. In analyses of risk of ESRD, women were followed until 31 December 2005 or death, death was treated as a censoring event. In analyses of risk of death, women were followed until 31 December 2004 or ESRD, ESRD was treated as a censoring event. Estimates of relative risk (RR) with 95% confidence intervals (CI) for ESRD and death according to selected risk factors were obtained by Cox regression analysis. Analyses were adjusted by including the relevant variables as covariates in the Cox models. As no cases with ESRD had been registered between 1967 and 1979, mothers who gave birth during this period were left truncated in the survival analyses before January 1980. Consequently, the counting process formulation of proportional hazards (Cox regression) was applied [23] . This method does not include mothers in the analysis until an event can be registered, i.e. a mother with her last birth in 1973 would be included in the analyses 7 years after birth and right censored 32 years after birth if she did not develop ESRD or die. The analyses were performed with the statistical packages SPSS 15 (SPSS Inc.) and S-Plus 8.0 (Insightful Corporation).
Results
Among the 639 018 included women, 2204 women had diabetes before pregnancy. Women with diabetes were older and had more adverse pregnancy outcomes than women without diabetes (Table 1) . Among the 2204 women with diabetes, 1481 women were diagnosed with diabetes before first pregnancy, 449 between first and second pregnancy and 274 between second and third pregnancy. Women who were diagnosed with diabetes before first pregnancy had only slightly increased risks of adverse pregnancy outcomes in first pregnancy as compared to women who were diagnosed after first pregnancy (Table 1) . Pre-eclampsia and other adverse pregnancy outcomes, except stillbirth, were LGA=large for gestational age; CI = confidence interval.
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Risk of ESRD and death in women with diabetes
Among the 639 018 included women, 490 developed ESRD 20 ± 9 years after first pregnancy and 13 743 died after 21 ± 9 years. As shown in Table 3 and Figure 1 , women with diabetes had a 46 times increased risk of ESRD, a 4.5 times increased risk of death due to all causes and a 7.0 times increased risk of cardiovascular death, as compared to women without diabetes. Causes of death were cardiovascular disease in 24 women, complications from diabetes in 76 women, malignant disease in 27 women and other causes in 16 women. For women with diabetes and only one pregnancy, RRs for ESRD and death were 55 (95% CI 37-81) and 4.2 (3.3-5.3), as compared to women without diabetes; for women with diabetes and two or more pregnancies, corresponding RRs were slightly lower, 33 (21-51) and 3.9 (3.1-4.9). Women who were diagnosed with diabetes before first pregnancy had a significantly increased risk of ESRD and death compared to women who were diagnosed with diabetes before second or third pregnancy (Table 3) . To analyse whether the increased risk of ESRD and death associated with diabetes changed during the study period, women were categorized into three groups based on year of first delivery: 1967-1975, 1976-1984 or 1985-1994 .
The cumulative proportion who had developed ESRD after 10 years of follow-up in these three time periods were 0.46, 0.67 and 0.35%, respectively; after 20 years the cumulative proportions were 4.0 and 1.2% (the last group had a mean follow-up period of 15 years, at that time 0.51% had developed ESRD). The cumulative proportions that had died after 10 years were 1.1, 1.3 and 0.60%, respectively; after 20 years the cumulative proportions were 8.0 and 3.8% (the last group had a mean follow-up period of 14 years, at that time 1.1% had died).
Risks of ESRD and death in women diagnosed with diabetes before first pregnancy and adverse pregnancy outcomes
Women diagnosed with diabetes before first pregnancy had the longest follow-up period and we therefore selected these women for the analysis of adverse pregnancy outcomes and later risks of ESRD and death. Inclusion of women who were diagnosed with diabetes mellitus after first pregnancy (but before second or third pregnancy) yielded, however, virtually identical results.
Compared to women who in their first pregnancy had an term birth without pre-eclampsia, women with term preeclampsia had no increased risk of ESRD or death, while women with a preterm birth without pre-eclampsia had an RR of 1.9 for ESRD and 1.5 for death (Tables 4 and 5 ) (Figure 2 ). Corresponding RRs after preterm pre-eclampsia were 2.8 and 2.2. RRs for cardiovascular death were 3.3 (95% CI 0.95-11) after term pre-eclampsia, 2.6 (1.1-6.0) after preterm birth without pre-eclampsia and 2.1 (0.61-6.9) after preterm pre-eclampsia. As pre-eclampsia and pregestational diabetes were associated with a lower number of lifetime pregnancies, we stratified the analyses according to this variable. Women with only one pregnancy who had pre-eclampsia or preterm birth had a significantly higher risk of ESRD or death as compared to women with two or more pregnancies who had a first pregnancy without pre-eclampsia or preterm birth; women with only one pregnancy and a preterm pre-eclampsia had the highest risk with RRs of 5.8 for ESRD and 3.5 for death (Tables 4 and 5 ). Women with two or more pregnancies who had pre-eclampsia and/or preterm birth in first pregnancy had no increased risks of ESRD and death. These findings were similar after adjustments. The Medical Birth Registry does not specifically register diabetic nephropathy, but urinary tract or kidney disease had been recorded before first pregnancy in 35 (1.6%) women with diabetes, in 24 (1.4%) women before second pregnancy and in 10 (1.5%) women before third pregnancy. Sixty-three women had urinary tract or kidney disease before at least one of her pregnancies. Among these, diagnoses related to glomerular disease, renal insufficiency or proteinuria were recorded for 30 women (1.4%). Excluding these women did not significantly change the effects of pre-eclampsia and preterm birth. 
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We further tested whether there was a significant interaction between diabetes and pre-eclampsia. In the analyses of all women, there was a near-significant negative interaction [RR for interaction variable 0.49 (0.24-1.02)], indicating that the effect of pre-eclampsia was lower in women with diabetes than in women without diabetes. In women with only one pregnancy, the interaction was significant [RR 0.36 (0.15-0.88)] but not in women with two or more pregnancies. There was no interaction between preterm birth and diabetes.
When deaths within 10 years after first birth were excluded, main results were virtually unchanged. Low birth weight offspring were also associated with increased risk of ESRD and death, although somewhat weaker than preterm birth (data not shown). Small-for-gestational-age or largefor-gestational-age offspring were not associated with ESRD or death. Stillbirth was associated with ESRD and death, implying a 3-to 4-fold excess risk. The associations were statistically significant also after adjustment for preeclampsia and preterm birth (data not shown). Caesarean section or congenital malformations of offspring tended to involve a 2-fold excess risk, but these associations were not statistically significant.
In women with their first delivery between 1967-1975, 1976-1984 or 1985-1994 , the effects of pre-eclampsia and preterm delivery on later risks of ESRD and death were similar.
Discussion
The present study showed that diabetic women who had pre-eclampsia or preterm birth had an increased long-term risk of ESRD and death. These effects were, however, only present in women with only one pregnancy and were weaker than in women without diabetes. As expected, women with diabetes more often had adverse pregnancy outcomes than women without diabetes.
We have recently shown that pre-eclampsia is associated with a four to five times increased risk of ESRD [6] in the general population. In the present study, we investigated this association in women with diabetes, as these women have a well-known excess risk of renal and cardiovascular disease. Some studies have indicated that pre-eclampsia involves an excess risk of progression to diabetic nephropathy [14, 24] , although this has been controversial. Ekbom et Adjusted for year of birth, age, marital status, stillbirth, congenital malformations of offspring and C-section in the first pregnancy. Women diagnosed with urinary tract or kidney disease or essential hypertension before first, second or third pregnancy were excluded. al. have shown that diabetic women with microalbuminuria had higher risks of preterm delivery and pre-eclampsia than diabetic women with normoalbuminuria, and women with diabetic nephropathy had even higher risks [25] . This finding suggests that pre-existing subclinical nephropathy could explain the association with later ESRD among women with diabetes. In our study, only ∼1.4% among the women with diabetes were registered with diagnoses related to nephropathy before at least one of her pregnancies. This relatively low prevalence as compared to other studies of proteinuria in young patients with diabetes [26, 27] may be due to low fertility in women with moderate or severe nephropathy. It should also be noted that microalbuminuria was not routinely monitored in diabetes until the late 1980s, and as we included patients who had their first pregnancy between 1967 and 1994, it is likely that most of the patients with reported kidney or urinary tract disease had manifest diabetic nephropathy. Manifest nephropathy with proteinuria and/or renal failure would be important information for the treating physicians and is likely to have been reported in most cases. As the main results were virtually unchanged after exclusion of women with urinary tract or kidney disease, we consider it unlikely that most of the increased risk associated with adverse pregnancy outcomes could be explained by pre-pregnancy subclinical diabetic nephropathy.
Endothelial dysfunction is associated with type 2 diabetes [28] , and has also been shown in young adults with uncomplicated type 1 diabetes, although it seems to manifest later in the course of the disease than in type 2 diabetes [29] . Recent studies have indicated that endothelial dysfunction may be an important mechanism in pre-eclampsia and placental dysfunction [30, 31] and several authors have suggested that persistent endothelial dysfunction may be the link between pre-eclampsia and later cardiovascular and renal disease [32, 33] . In groups of women where the occurrence of endothelial dysfunction is higher than in the general population, as in women with diabetes [28, 29] , pre-eclampsia might not predict women prone to develop endothelial dysfunction to the same extent as in the general population. This could explain our finding that the excess risks associated with pre-eclampsia and preterm birth were less in diabetic women than previously reported in women without diabetes [6] .
Lifetime parity seemed to be an important factor. Women who had only one pregnancy and pre-eclampsia and/or preterm birth had increased risk of ESRD and death, while women with two or more pregnancies who had preeclampsia or preterm birth in first pregnancy did not have an increased risk when compared to women who did not suffer these complications in their first pregnancy. We have previously shown that women with a complicated first Pregnancy and risk of ESRD in diabetic women 3605 pregnancy less often have a second pregnancy [6] . This was also true for women with diabetes and might be explained by the women's fear of another complicated pregnancy or their doctors' advice against further pregnancies. The subsequent fertility is probably most reduced in women with the most severely affected pregnancies who also might have the highest risk of later ESRD or death. Obesity and increased oxidative stress often observed in women with diabetes are associated with both lower fertility and progression of renal disease [34] and may also account for the association between low fertility and the long-term risks of ESRD and death.
In women with diabetes, large-for-gestational-age offspring were more common in preterm than in term births. This is probably a sign of poor glycaemic control during pregnancy, also suggested by the higher rates of congenital malformations and stillbirths among the preterm births. The rates of stillbirth, large-for-gestational-age offspring and preterm birth decreased markedly during the study period (data not shown), parallel to the improvement of diabetes care in pregnancy that took place in the 1980s. The fact that large-for-gestational-age offspring or congenital malformations did not predict ESRD or death does, however, argue against poorly controlled blood glucose during pregnancy as an important risk factor for later ESRD or death.
Strengths of the present study comprise the inclusion of a large national cohort of women with long-term follow-up and complete registration of exposures, outcomes and censoring for death. Furthermore, the primary outcomes, ESRD and death, are well documented. The validity of the main variable of exposure, pregestational diabetes, has been found to be high [35] .
The present study has, however, three main weaknesses. First, the Medical Birth Registry of Norway does not record information on duration of diabetes prior to first pregnancy. Second, the Registry did not differentiate between type 1 and type 2 diabetes until 1998. Still, it should be noted that type 2 diabetes was rare in this age group in Norway during the inclusion period from 1967 to 1994. The mean duration of observation for women with type 2 diabetes would be considerably shorter than for women with type 1 diabetes. By excluding the women who were diagnosed with diabetes after first pregnancy from the main analyses, we probably excluded most of those with type 2 diabetes, among whom very few developed ESRD during follow-up. Third, data on treatment or glucose control were not registered. Management of diabetes in pregnancy had undergone large changes during the observation period, but since the early 1970s, most of these women were been seen by an endocrinologist every 2-4 weeks and the management has followed international standards. Our results show that the long-term prognosis for women with diabetes improved markedly during the observation period, but the effects of pre-eclampsia and preterm birth remained the same. In conclusion, we find it unlikely that data on duration and treatment of diabetes would have significantly altered our findings.
There is also a possibility of uncontrolled confounding as we do not have data available on smoking or obesity, which have also been associated with both pre-eclampsia and chronic renal disease as well as mortality [36] [37] [38] . We do, however, find it unlikely that these possible confounders could have significantly changed our results.
Conclusion
In this long-term follow-up study, we conclude that women with diabetes had higher risks of adverse pregnancy outcomes than women without diabetes and that these significantly predicted long-term risks of ESRD and death in women with only one pregnancy. Preterm pre-eclampsia was associated with a particularly poor prognosis. In women with diabetes and two or more pregnancies, adverse pregnancy outcomes were not associated with increased risk of ESRD or death. Furthermore, the effect of pre-eclampsia and preterm birth was lower in women with diabetes than in women without diabetes. This might be explained by a higher prevalence of pregestational endothelial dysfunction in women with diabetes. The long-term prognosis for women with diabetes improved during the observation period, but the effects of adverse pregnancy-related outcomes remained the same.
